Orchid Pharma Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2013
2015
2016
2017
2018
Net Income before Extraordinaries
5,725
3,886
2,962
4,523
-
Depreciation, Depletion & Amortization
2,519
3,246
1,453
1,410
-
Other Funds
-
-
257
-
-
Funds from Operations
2,648
1,496
710
890
2,195
Changes in Working Capital
795
6,693
182
1,872
-
Net Operating Cash Flow
1,853
5,196
528
982
-
Capital Expenditures
11,160
837
15
85
-
Sale of Fixed Assets & Businesses
-
767
14,173
-
-
Purchase/Sale of Investments
532
-
-
2
-
Net Investing Cash Flow
9,861
13,336
15
87
-
Issuance/Reduction of Debt, Net
10,177
5,206
141
1,474
-
Net Financing Cash Flow
10,179
4,469
214
1,474
-
Net Change in Cash
1,535
3,671
756
579
-
Free Cash Flow
13,013
6,033
542
897
-
Change in Capital Stock
2
737
184
-
-

About Orchid Pharma

View Profile
Address
Orchid Towers
Chennai Tamil Nadu 600034
India
Employees -
Website http://www.orchidpharma.com
Updated 09/14/2018
Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectibles, veterinary products, and non-antibiotics. The company was founded by by Kailasam Raghavendra Rao on July 1, 1992 and is headquartered in Chennai, India.